Generalized Anxiety Disorder Clinical Trial
Official title:
Psychodynamic Versus Cognitive Behavioral Internet-Delivered Guided Self-help for Generalized Anxiety Disorder: A Randomized Controlled Trial
Verified date | March 2011 |
Source | Linkoeping University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Sweden: Regional Ethical Review Board |
Study type | Interventional |
The objective is to test if Internet-delivered cognitive behavior therapy (iCBT) or Internet-delivered psychodynamic therapy (iPDT) performs better for a population with generalized anxiety disorder (GAD), compared to a wait-list control condition.
Status | Completed |
Enrollment | 81 |
Est. completion date | December 2010 |
Est. primary completion date | October 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - fulfill the diagnostic criteria for GAD according to DSM-IV - have access to the Internet - have good knowledge of the Swedish language Exclusion Criteria: - recent (during last 6 weeks) change in psychiatric medication - presently in any other psychological treatment - severe depression - suicidal ideation |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Sweden | Linköping University | Linköping | Östergötland |
Lead Sponsor | Collaborator |
---|---|
Linkoeping University | Stockholm University |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Penn State Worry Questionnaire (PSWQ) | Change from baseline in anxiety symptoms to two weeks post treatment. | Two weeks pre treatment to two weeks post treatment. | No |
Secondary | Montgomery Åsberg Depression Rating Scale-Self Rated (MADRS-S) | Change from baseline in depressive symptoms to two weeks post treatment. | Two weeks pre treatment to two weeks post treatment | Yes |
Secondary | Quality of Life Inventory (QOLI) | Change from baseline in quality of life status to two weeks post treatment. | Two weeks pre treatment to two weeks post treatment | No |
Secondary | Beck Depression Inventory (BDI) | Change from baseline in depressive symptoms to two weeks post treatment. | Two weeks pre treatment to two weeks post treatment | No |
Secondary | Beck Anxiety Inventory (BAI) | Change from baseline in anxiety symptoms to two weeks post treatment. | Two weeks pre treatment to two weeks post treatment | No |
Secondary | Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness (TIC-P) | Change from baseline in societal cost of illness to two weeks post treatment. | Two weeks pre treatment to two weeks post treatment | No |
Secondary | State Trait Anxiety Inventory (STAI) | Change from baseline in anxiety symptoms to two weeks post treatment. | Two weeks pre treatment to two weeks post treatment | No |
Secondary | Generalized Anxiety Disorder Questionnaire IV (GAD-Q IV) | Change from baseline in anxiety symptoms to two weeks post treatment. | Two weeks pre treatment to two weeks post treatment | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03420456 -
Transcranial Pulse Near-Infrared Light in Generalized Anxiety Disorder: a Placebo-Controlled Study
|
N/A | |
Active, not recruiting |
NCT05530642 -
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
|
N/A | |
Withdrawn |
NCT02382224 -
Worry Exposure for Generalized Anxiety Disorder
|
N/A | |
Completed |
NCT02306356 -
Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting
|
N/A | |
Completed |
NCT02256566 -
Cognitive Training for Mood and Anxiety Disorders
|
N/A | |
Completed |
NCT01958788 -
Testing Beliefs About Uncertainty in the Treatment of Generalized Anxiety Disorder
|
N/A | |
Completed |
NCT01681329 -
Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Disorder
|
N/A | |
Completed |
NCT01342120 -
PHARMO Institute Seroquel Safety Study
|
N/A | |
Completed |
NCT01337713 -
Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD)
|
N/A | |
Completed |
NCT01201967 -
A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients
|
Phase 4 | |
Completed |
NCT01203293 -
Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector
|
Phase 1 | |
Completed |
NCT01971203 -
Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat
|
N/A | |
Completed |
NCT00961298 -
An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder
|
Phase 4 | |
Completed |
NCT00744627 -
Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.
|
Phase 3 | |
Completed |
NCT00711737 -
Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
|
N/A | |
Terminated |
NCT01244711 -
Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
|
Phase 4 | |
Completed |
NCT00515242 -
Therapeutic Massage for Generalized Anxiety Disorder
|
Phase 1/Phase 2 | |
Completed |
NCT00537615 -
An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers
|
Phase 1 | |
Completed |
NCT00525226 -
Evaluating the Effects of Stress in Pregnancy
|
N/A | |
Completed |
NCT00620776 -
Combined Treatment for Generalized Anxiety Disorder (GAD)
|
Phase 2 |